Saint Lucians could soon benefit from greater access to affordable medicines following the signing of a memorandum of understanding (MOU) between the government and the Indian Pharmacopoeia Commission (IPC) of India’s Ministry of Health and Family Welfare.
The agreement establishes a framework for cooperation in the regulation of medicines and the exchange of information between the two countries.
A key component of the arrangement is Saint Lucia’s acceptance of the Indian Pharmacopoeia as a recognised standard for medicines. The move is expected to strengthen quality assurance measures while simplifying the process for importing pharmaceutical products from India.
The agreement will also allow Saint Lucia to accept certificates of analysis issued by Indian manufacturers operating under Indian Pharmacopoeia standards, removing the need for duplicate testing of those medicines locally.
Officials say this could help reduce costs, speed up access to medicines and support the wider availability of generic drugs on the island.
India’s High Commissioner to Saint Lucia Subhash Gupta said the agreement forms part of a broader vision for international collaboration in healthcare.
“Saint Lucia’s recognition of the Indian Pharmacopoeia will extend importation and quality assurance registration of the Indian Pharmaceutical products, facilitating access to affordable high-quality generic medicines,” he said.
“This MOU further presents an opportunity to replicate the world’s largest medicine supply system, providing affordable medicines to the people of the country through dedicated outlets. This initiative aligns with the Indian philosophy that the entire world is one family, and this MOU fosters global unity in the realm of health and wellbeing.”
Health, Wellness and Nutrition Minister Moses Jn. Baptiste said the agreement supports the government’s objective of improving access to healthcare and could serve as the foundation for a broader partnership with India.
“This landmark Pharmacopoeia MOU aligns perfectly with our government’s highest priority, which is delivering accessible, high-quality universal health care to every citizen of Saint Lucia,” Jn. Baptiste said.
“By standardising our regulatory framework, we are unlocking immediate access to safe, affordable and lifesaving generic medicines.”
The minister said the partnership could also create opportunities for Saint Lucia to pursue additional healthcare initiatives and acquire critical medical infrastructure.
Jn. Baptiste said the agreement could open the door to additional healthcare initiatives, including generic medicine programmes and the acquisition of critical medical infrastructure such as haemodialysis units, cancer treatment equipment and sea ambulances.
